Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis

Z Dai, X Peng, Y Guo, X Shen, W Ding, J Fu… - Journal of Cancer …, 2023 - Springer
Purpose Colon cancer presents challenges to clinical diagnosis and management due to its
high heterogeneity. For more efficient and convenient diagnosis and treatment of colon …
被引用次数：4 相关文章

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis

Z Dai, X Peng, Y Guo, X Shen… - Journal of cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Colon cancer presents challenges to clinical diagnosis and management due to its
high heterogeneity. For more efficient and convenient diagnosis and treatment of colon …

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Z Dai, X Peng, Y Guo, X Shen, W Ding, J Fu… - Journal of Cancer …, 2022 - europepmc.org
Purpose Colon cancer presents challenges to clinical diagnosis and management due to its
high heterogeneity. For more efficient and convenient diagnosis and treatment of colon …

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Z Dai, X Peng, Y Guo, X Shen, W Ding… - Journal of Cancer …, 2023 - search.ebscohost.com
Purpose: Colon cancer presents challenges to clinical diagnosis and management due to its
high heterogeneity. For more efficient and convenient diagnosis and treatment of colon …

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis

Z Dai, X Peng, Y Guo, X Shen, W Ding… - Journal of Cancer …, 2023 - search.proquest.com
Purpose Colon cancer presents challenges to clinical diagnosis and management due to its
high heterogeneity. For more efficient and convenient diagnosis and treatment of colon …